Health Canada drug identification number

DIN 02234503 — APO-TERAZOSIN 2 MG

APO-TERAZOSIN is a tablet of Terazosin marketed by APOTEX INC. The full Terazosin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02234503
Brand name
APO-TERAZOSIN
Active ingredient
Terazosin
Strength
2 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
APOTEX INC
Health Canada status
MARKETED
Drug class
Alpha-1 adrenergic receptor blocker (antihypertensive / BPH agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Terazosin products

DINBrandStrengthFormManufacturerStatus
02234502 APO-TERAZOSIN 1 MG TABLET APOTEX INC MARKETED
02234505 APO-TERAZOSIN 10 MG TABLET APOTEX INC MARKETED
02234504 APO-TERAZOSIN 5 MG TABLET APOTEX INC MARKETED
02243518 PMS-TERAZOSIN 1 MG TABLET PHARMASCIENCE INC MARKETED
02243521 PMS-TERAZOSIN 10 MG TABLET PHARMASCIENCE INC MARKETED
02243519 PMS-TERAZOSIN 2 MG TABLET PHARMASCIENCE INC MARKETED
02243520 PMS-TERAZOSIN 5 MG TABLET PHARMASCIENCE INC MARKETED
02230805 TEVA-TERAZOSIN 1 MG TABLET TEVA CANADA LIMITED DORMANT
02230808 TEVA-TERAZOSIN 10 MG TABLET TEVA CANADA LIMITED DORMANT
02230806 TEVA-TERAZOSIN 2 MG TABLET TEVA CANADA LIMITED DORMANT
02230807 TEVA-TERAZOSIN 5 MG TABLET TEVA CANADA LIMITED DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.